2024
Psychopharmacological Treatment of Schizophrenia
Singh N, Ganesh S, D'Souza D. Psychopharmacological Treatment of Schizophrenia. 2024, 729-737. DOI: 10.1016/b978-0-323-95702-1.00177-9.Peer-Reviewed Original ResearchAntipsychotic drugsPositive symptoms of schizophreniaPharmacological treatment of schizophreniaTreatment-resistant schizophreniaPharmacological treatmentSymptoms of schizophreniaTreatment of schizophreniaAcute psychotic episodeNeuroleptic malignant syndromeNegative symptomsPositive symptomsExtrapyramidal symptomsPsychotic episodeCognitive deficitsCognitive symptomsMalignant syndromeSchizophreniaPrevent relapseSide effectsMaintenance treatmentLong-actingDopamineAssociated with significant side effectsMedication adherenceProportion of patients
2022
Catatonia and Neuroleptic Malignant Syndrome in Patients With Cerebral Palsy: Two Case Reports and a Systematic Review of the Literature
Barnett B, Balaji D, Weleff J, Carroll B. Catatonia and Neuroleptic Malignant Syndrome in Patients With Cerebral Palsy: Two Case Reports and a Systematic Review of the Literature. Journal Of The Academy Of Consultation-Liaison Psychiatry 2022, 64: 277-293. PMID: 36586471, DOI: 10.1016/j.jaclp.2022.12.008.Peer-Reviewed Original ResearchConceptsCerebral palsyBaclofen withdrawalIntrathecal baclofen withdrawalAllied Health LiteraturePrevalence of catatoniaSpasticity managementIntrathecal baclofenCumulative IndexHealth LiteratureReports of catatoniaRecurrent self-limiting feverGroup of movement disordersService databasePalsyLifetime prevalenceOvid MEDLINESystematic reviewNeuroleptic malignant syndromePatient populationCase reportMovement disordersPsychotic disordersRoutine treatmentInduced neuroleptic malignant syndromeMalignant syndrome
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply